Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Apr;28(4):446-50.
doi: 10.1136/gut.28.4.446.

Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids

Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids

F Stellaard et al. Gut. 1987 Apr.

Abstract

In patients with progressive systemic sclerosis, impaired motor function of the small intestine may lead to bacterial overgrowth causing diarrhoea, steatorrhoea and malabsorption. As unconjugated serum bile acids have been proposed as markers for small bowel bacterial overgrowth, we studied individual unconjugated serum bile acids in 36 patients with progressive systemic sclerosis. These patients had significantly higher serum concentrations of unconjugated cholic acid (median 0.18; range 0.05-30.75 v 0.09; 0.01-0.19 mumol/l, p less than 0.001) and chenodeoxycholic acid (0.10; 0.01-6.83 v 0.04; 0.01-0.39 mumol/l, p less than 0.025) than healthy controls (n = 16). This difference was mainly due to patients with diarrhoea (n = 10), who had significantly higher concentrations of unconjugated serum bile acids than patients with normal bowel habit (cholic acid median 0.55 v 0.16 mumol/l, p less than 0.001; chenodeoxycholic acid 0.75 v 0.07 mumol/l; p less than 0.005). All patients with raised unconjugated serum bile acids had oesophageal motility disorders. These results confirm a relationship between motility disorders and bacterial overgrowth in patients with progressive systemic sclerosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1966 Jun 16;274(24):1339-44 - PubMed
    1. J Clin Invest. 1966 Jun;45(6):956-62 - PubMed
    1. Lancet. 1969 Feb 1;1(7588):219-20 - PubMed
    1. Gut. 1969 Mar;10(3):185-93 - PubMed
    1. Gut. 1969 Apr;10(4):285-92 - PubMed

Substances